tc14012 and Corneal-Neovascularization

tc14012 has been researched along with Corneal-Neovascularization* in 2 studies

Other Studies

2 other study(ies) available for tc14012 and Corneal-Neovascularization

ArticleYear
The effect of TC14012 on alkali burn-induced corneal neovascularization in mice.
    Ophthalmic research, 2014, Volume: 52, Issue:1

    To observe the effect of TC14012 (a CXCR4 antagonist and CXCR7 agonist) on alkali burn-induced corneal neovascularization (CNV) in a mouse model.. CNV was induced in vivo by alkali burns on the corneas of BALB/c mice. A total of 54 mice treated with alkali burns were randomly divided into 3 groups, each of which received one of the following treatments: bilateral subconjunctival injections of TC14012 for 3 consecutive days, bilateral subconjunctival injections of balanced saline (BS) for 3 consecutive days or no treatment (blank control). The areas of CNV were measured on days 3, 7 and 14 after the alkali burns. CXCR4, CXCR7, vascular endothelial growth factor (VEGF) and matrix metalloproteinase (MMP) mRNAs were detected and quantified by real-time reverse transcription PCR on days 7 and 14. Additionally, the expression of the proteins CXCR4, CXCR7, VEGF, β-arrestin 2, total ERK1/2 and phospho-ERK1/2 was determined by Western blotting.. On day 7 after the alkali burns, the CNV area, VEGF, MMP-2 and MMP-9 mRNA levels, and VEGF, β-arrestin 2 and phospho-ERK1/2 protein levels were increased in the TC14012 group compared with the nontreatment and BS groups. However, on day 14, the CNV area, CXCR4, CXCR7, VEGF, MMP-2 and MMP-9 mRNA levels, and the CXCR4, CXCR7, VEGF and β-arrestin 2 protein levels were significantly decreased in the TC14012 group.. TC14012 initially enhanced alkali burn-induced CNV but reduced CNV in later stages. In addition to CXCR4, CXCR7 is involved in the pathogenesis of CNV.

    Topics: Animals; Burns, Chemical; Conjunctiva; Corneal Neovascularization; Disease Models, Animal; Eye Burns; Gene Expression Regulation; Injections, Intraocular; Male; Matrix Metalloproteinases; Mice; Mice, Inbred BALB C; Oligopeptides; Real-Time Polymerase Chain Reaction; Receptors, CXCR; Receptors, CXCR4; RNA, Messenger; Sodium Hydroxide; Vascular Endothelial Growth Factor A

2014
The SDF-1/CXCR4 ligand/receptor pair is an important contributor to several types of ocular neovascularization.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2007, Volume: 21, Issue:12

    Hypoxia causes increased expression of several proteins that have the potential to promote neovascularization. Vascular endothelial growth factor (VEGF) is up-regulated by hypoxia in the retina and plays a central role in the development of several types of ocular neovascularization, but the effects of other hypoxia-regulated proteins are less clear. Stromal-derived factor-1 (SDF-1) and its receptor, CXCR4, have hypoxia response elements in the promoter regions of their genes and are increased in hypoxic liver and heart. In this study, we found that SDF-1 and CXCR4 are increased in hypoxic retina, with SDF-1 localized in glial cells primarily near the surface of the retina and CXCR4 localized in bone marrow-derived cells. Glial cells also expressed CXCR4, which suggested the possibility of autocrine stimulation, but influx of bone marrow-derived cells is the major source of increased levels of CXCR4. High levels of VEGF in the retina in the absence of hypoxia also increased levels of Cxcr4 and Sdf1 mRNA. CXCR4 antagonists reduced influx of bone marrow-derived cells into ischemic retina and strongly suppressed retinal neovascularization, VEGF-induced subretinal neovascularization, and choroidal neovascularization. These data suggest that SDF-1 and CXCR4 contribute to the involvement of bone marrow-derived cells and collaborate with VEGF in the development of several types of ocular neovascularization. They provide new targets for therapeutic intervention that may help to bolster and supplement effects obtained with VEGF antagonists.

    Topics: Animals; Antigens, Differentiation; Bone Marrow Cells; Chemokine CXCL12; Corneal Neovascularization; Humans; Hypoxia; Ischemia; Leukocyte Common Antigens; Mice; Mice, Inbred C57BL; Mice, Transgenic; Oligopeptides; Platelet Endothelial Cell Adhesion Molecule-1; Pyridines; Receptors, CXCR4; Retina; Retinal Neovascularization; Vascular Endothelial Growth Factor A

2007